It looks like Haleon plc ( LON:HLN ) is about to go ex-dividend in the next three days. The ex-dividend date is ...

The latest announcement is out from Haleon PLC ( (GB:HLN) ).

Haleon PLC HLN shares rallied 1.13% to £3.59 Wednesday, on what proved to be an all-around favorable trading session for the ...

Haleon plc (NYSE:HLN) is one of the best NYSE stocks to buy under $20. In a report released on August 4, Morgan Stanley ...

Haleon PLC closed 15.18% short of its 52-week high of £4.20, which the company reached on May 30th.

David Hayes has given his Buy rating due to a combination of factors that distinguish Haleon PLC from its competitors. The adjustments needed for Haleon’s second-quarter performance are ...

Haleon PLC is a consumer healthcare company and provides personal healthcare products. The group conducts business internationally across five consumer healthcare categories: Oral Health, Pain ...

Investors in Haleon plc(LON:HLN) had a good week, as its shares rose 4.3% to close at UK£3.68 following the release of its interim results. It was a credible result overall, with revenues of UK£ ...

Haleon plc has seen slight growth since its separation from GSK, with a 0.49% increase in YoY gains. See why I recommend a hold rating for HLN stock.

GSK Plc will sell its remaining stake in Haleon Plc for £1.25 billion ($1.6 billion), completing the drugmaker’s separation from the consumer health company.

Consumer health giant Haleon Plc is exploring a potential divestment of some smoking cessation products as it seeks to offload non-core businesses, people familiar with the matter said.

On November 29, 2022, Haleon plc (NYSE:HLN) stock closed at $6.76 per share. One-month return of Haleon plc (NYSE:HLN) was 11.92%, and in three months its shares gained 13.04% of their value.